LifeScience PLUS today announced the introduction of its proven fast-acting BloodSTOP hemostatic products in global markets. The company’s patent pending hemostatic technology brings a new level of efficacy to the wound care market.
Recent Posts
- America’s Lifeblood is in Crisis: A Novel Hemostatic Dressing Provides Hope
- Bleeding Out
- LifeScience PLUS launches revolutionary new hemostatic wound healing solution for donor sites
- BloodSTOP iX Advanced Hemostat Used During a Siamese Twin Separation Surgery for the First Time
- Mass Shootings have become a National Crisis, but BloodSTOP iX Trauma Matrix Offers Hope to Save Lives